1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, September 2016 (p20)

Biopharmaceutical Analysis & Statistics, September 2016 (p20)

24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

571-600 of about 1500 reports

Purchase Reports From Reputable Market Research Publishers

Ready-to-drink Protein Innovation Report 2016

Ready-to-drink Protein Innovation Report 2016

  • $ 971
  • Industry report
  • September 2016
  • by Zenith Global Ltd

Zenith’s Ready-to-drink Protein Innovation Report 2016 provides a comprehensive overview of current trends in new product development in the ready-to-drink protein market. By featuring over 60 innovative ...

  • Industries : Biopharmaceutical, Beverage, Soft Drink
  • Countries : World, Europe
Medical Affairs Reputations: Growth Hormone Deficiency (EU5)

Medical Affairs Reputations: Growth Hormone Deficiency (EU5)

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

Can Medical Affairs teams from branded players maintain dominance over biosimilars? Two medical affairs teams lead in the EU5 growth hormone deficiency (GHD) treatment market, but for how long? Competition ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Biosimilar - Global Market Outlook (2016-2022)

Biosimilar - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • September 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Biosimilars market is estimated to be $3.5 billion in 2015 with a CAGR of 23.8% is poised to reach $15.6 billion by 2022. High end adoption of off patented drugs ...

  • Industries : Biopharmaceutical, Generic Drug, Biotechnology
  • Countries : World, Asia, Europe, North America
Fabry Disease - Pipeline Review, H2 2016

Fabry Disease - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Fabry Disease - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Fabry Disease - Pipeline Review, H2 2016’, provides an overview of the Fabry Disease pipeline landscape. The report provides ...

  • Industries : Pathology, Therapy, Pharmaceutical, Mental Health, Healthcare
  • Countries : United States, World, Europe
3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘3 Phosphoinositide Dependent Protein Kinase 1 (PDPK1 or EC 2.7.11.1) ...

  • Industries : Pathology, Therapy, Pharmaceutical, Biopharmaceutical
  • Countries : United States, World
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States
Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - Pipeline Review, H2 2016

Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Galectin 3 (35 kDa Lectin or Carbohydrate Binding Protein 35 or Galactose Specific Lectin 3 or Galactoside Binding Protein or IgE Binding Protein or Laminin Binding Proteinor Mac 2 Antigen or LGALS3) - ...

  • Industries : Therapy, Pathology
  • Countries : United States
DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 or p460 or PRKDC or EC 2.7.11.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘DNA Dependent Protein Kinase Catalytic Subunit (DNAPK1 ...

  • Industries : Therapy, Biopharmaceutical, Genomics
  • Countries : United States, World, France
Surface Protein gp120 - Pipeline Review, H2 2016

Surface Protein gp120 - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Surface Protein gp120 - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Surface Protein gp120 - Pipeline Review, H2 2016’, provides in depth analysis on Surface Protein gp120 targeted ...

  • Industries : Pathology, Therapy, Healthcare
  • Countries : United States
Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) - Pipeline Review, H2 2016

Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Mitogen Activated Protein Kinase Kinase Kinase 5 (Apoptosis Signal Regulating Kinase 1 or MAPK/ERK Kinase Kinase 5 or MAP3K5 or EC 2.7.11.25) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ...

  • Industries : Therapy, Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : World
Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein Homolog or PMEL) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Melanocyte Protein PMEL (ME20M or Melanocyte Protein Pmel 17 or Melanocytes Lineage Specific Antigen GP100 or Melanoma Associated ME20 Antigen or P1 or P100 or Premelanosome Protein or Silver Locus Protein ...

  • Industries : Therapy
  • Countries : United States, World
Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Alpha L-Iduronidase (IDUA or EC 3.2.1.76) - Pipeline Review, H2 2016’, provides in depth analysis ...

  • Industries : Biopharmaceutical, Therapy, Pathology, Biotechnology, Pharmaceutical
  • Countries : United States
Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016

Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Von Willebrand Disease (Factor VIII Deficiency) Global Clinical Trials ...

  • Industries : Pathology, Biopharmaceutical, Therapy, Biotechnology
  • Countries : World
Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2016

Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Bronchiolitis Obliterans Global Clinical Trials Review, H2, 2016" provides an overview of ...

  • Industries : Therapy, Pharmaceutical, Biological Therapy
  • Countries : World
Histone Lysine N Methyltransferase EHMT2 (Euchromatic Histone Lysine N Methyltransferase 2 or HLA B Associated Transcript 8 or Histone H3 K9 Methyltransferase 3 or Lysine N Methyltransferase 1C or Protein G9a or EHMT2 or EC 2.1.1.43) - Pipeline Review, H2

Histone Lysine N Methyltransferase EHMT2 (Euchromatic Histone Lysine N Methyltransferase 2 or HLA B Associated Transcript 8 or Histone H3 K9 Methyltransferase 3 or Lysine N Methyltransferase 1C or Protein G9a or EHMT2 or EC 2.1.1.43) - Pipeline Review, H2

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Histone Lysine N Methyltransferase EHMT2 (Euchromatic Histone Lysine N Methyltransferase 2 or HLA B Associated Transcript 8 or Histone H3 K9 Methyltransferase 3 or Lysine N Methyltransferase 1C or Protein ...

  • Industries : Pathology
  • Countries : World
Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Human Cytomegalovirus Envelope Glycoprotein B (gB) - Pipeline Review, H2 2016’, provides ...

  • Industries : Pathology
  • Countries : United States
Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Protein Phosphatase 2A (PP2A or EC 3.1.3.16) - Pipeline Review, H2 2016’, provides in depth ...

  • Industries : Therapy, Pathology, Cancer, Biotechnology, Biopharmaceutical
  • Countries : United States
Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Pipeline Review, H2 2016

Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 or GPR129 or FFAR4) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Free Fatty Acid Receptor 4 (G Protein Coupled Receptor 120 or G Protein Coupled Receptor 129 or G Protein Coupled Receptor GT01 or Omega 3 Fatty Acid Receptor 1 or G Protein Coupled Receptor PGR4 or GPR120 ...

  • Industries : Therapy, Pathology, Pharmaceutical
  • Countries : World
Hemophilia A Global Clinical Trials Review, H2, 2016

Hemophilia A Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Hemophilia A Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Hemophilia A Global Clinical Trials Review, H2, 2016" provides an overview of Hemophilia A clinical trials ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Healthcare
  • Countries : World
Hemophilia B Global Clinical Trials Review, H2, 2016

Hemophilia B Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Hemophilia B Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Hemophilia B Global Clinical Trials Review, H2, 2016" provides an overview of Hemophilia B clinical trials ...

  • Industries : Pathology, Drug Discovery and Development, Pharmaceutical, Healthcare
  • Countries : World
TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30) - Pipel

TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Receptor Type I or ALK5 or TGFBR1 or EC 2.7.11.30) - Pipel

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

TGF Beta Receptor Type 1 (Activin A Receptor Type II Like Protein Kinase Of 53kD or Activin Receptor Like Kinase 5 or Serine/Threonine Protein Kinase Receptor R4 or Transforming Growth Factor Beta Recepto ...

  • Industries : Therapy
  • Countries : World, United States
Mast Cell Leukemia Global Clinical Trials Review, H2, 2016

Mast Cell Leukemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Mast Cell Leukemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Mast Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of Mast Cell Leukemia ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World
Neoplastic Syndrome Global Clinical Trials Review, H2, 2016

Neoplastic Syndrome Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Neoplastic Syndrome Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Neoplastic Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Neoplastic ...

  • Industries : Therapy, Pharmaceutical, Cancer
  • Countries : World
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical ...

  • Industries : Therapy, Pharmaceutical, Biological Therapy, Cancer, Biotechnology, Biopharmaceutical, Pathology
  • Countries : World
Emerging Ingredients in Bakery and Cereals; Opportunities to capitalize on key health trends with emerging ingredients

Emerging Ingredients in Bakery and Cereals; Opportunities to capitalize on key health trends with emerging ingredients

  • $ 1450
  • Industry report
  • August 2016
  • by GlobalData

Summary The bakery and cereals sector is under increasing pressure, with refined carbohydrates being shunned in favor of whole grains and high-protein options. Manufacturers must respond quickly by aligning ...

  • Industries : Bakery and Pastry, Food Ingredient, Food Ingredient, Cereal Products, Food
  • Countries : World
Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2016

Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2016

  • $ 1500
  • Company report
  • August 2016
  • by Global Markets Direct

Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2016 Summary Global Markets Direct’s, ‘Reliance Life Sciences Pvt. Ltd. - Product Pipeline Review - 2016’, provides an overview of the ...

  • Industries : Research and Development, Biopharmaceutical, Therapy
  • Countries : India, World
Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2016

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Cell Division Protein FtsZ (ftsz) - Pipeline Review, H2 2016’, provides in depth analysis on Cell Division ...

  • Industries : Therapy
  • Countries : World, United States
Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Probable ATP Dependent RNA Helicase DDX58 (DEAD Box Protein 58 or RIG I Like Receptor 1 or Retinoic Acid Inducible Gene 1 Protein or DDX58 or EC 3.6.4.13) - Pipeline Review, H2 2016 Summary Global Markets ...

  • Industries : Pathology, Therapy, Pharmaceutical
  • Countries : World, United States, Europe
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC ...

  • Industries : Therapy, Biopharmaceutical, Biotechnology, Biological Therapy, Pharmaceutical, Pathology
  • Countries : United States, World
Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H2 2016

Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Tyrosine Protein Kinase Mer (Proto Oncogene c Mer or Receptor Tyrosine Kinase MerTK or MERTK or EC 2.7.10.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Tyrosine Protein Kinase Me ...

  • Industries : Cancer, Therapy, Pathology, Biopharmaceutical
  • Countries : United States, World

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.